Optimized technique for subretinal injections in mice

Methods in Molecular Biology

Volumn 935, Issue , 2013, Pages 343-349

  Mühlfriedel, Regine ^a   Michalakis, Stylianos ^b   Garrido, Marina Garcia ^a   Biel, Martin ^b   Seeliger, Mathias W ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Ablation; Bleb formation; Gene delivery; Mouse eye; Photoreceptor cell; Recombinant adeno associated virus; Retina; Subretinal injection; Transscleral pars plana injection

Indexed keywords

ADENO ASSOCIATED VIRUS; ANESTHESIA; ANIMAL; ARTICLE; EQUIPMENT DESIGN; GENE TRANSFER; GENE VECTOR; GENETICS; INSTRUMENTATION; INTRAOCULAR DRUG ADMINISTRATION; METABOLISM; METHODOLOGY; MOUSE; RETINA;

ANESTHESIA; ANIMALS; DEPENDOVIRUS; EQUIPMENT DESIGN; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; INJECTIONS, INTRAOCULAR; MICE; RETINA;

ADENO-ASSOCIATED VIRUS; ANIMALIA; MUS;

EID: 84871958654     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-080-9-24     Document Type: Article

References (22)

1. McCown TJ (2005) Adeno-associated virus (AAV) vectors in the CNS. Curr Gene Ther 5:333-338 (Review) (Pubitemid 40895017)
2. Marks WJ Jr, Ostrem JL, Verhagen L et al (2008) Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: An open-label, phase I trial. Lancet Neurol 7:400-408
3. Den Hollander AI, Black A, Bennett J (2010) Lighting a candle in the dark: Advances in genetics and gene therapy of recessive retinal dystrophies. J Clin Invest 120:3042-3053
4. Bainbridge JW, Smith AJ, Barker SS et al (2008) Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med 358:2231-2239 (Pubitemid 351724452)
5. Bennett J, Ashtari M, Wellman J et al (2012) AAV2 gene therapy readministration in three adults with congenital blindness. Sci Transl Med 4, 120ra15
6. Jacobson SG, Cideciyan AV, Ratnakaram R et al (2012) Gene therapy for leber congenital amaurosis caused by RPE65 mutations: Safety and ef fi cacy in 15 children and adults followed up to 3 years. Arch Ophthalmol 130:9-24
7. Timmers AM, Zhang H, Squitieri A et al (2001) Subretinal injections in rodent eyes: Effects on electrophysiology and histology of rat retina. Mol Vis 7:131-137 (Pubitemid 36153662)
8. Johnson CJ, Berglin L, Chrenek MA et al (2008) Technical brief: Subretinal injection and electroporation into adult mouse eyes. Mol Vis 14:2211-2226
9. Busskamp V, Duebel J, Balya D et al (2010) Genetic reactivation of cone photoreceptors restores visual responses in retinitis pigmentosa. Science 329:413-417
10. Price J, Turner D, Cepko C et al (1987) Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer. Proc Natl Acad Sci U S A 84:156-160 (Pubitemid 17013593)
11. Schlichtenbrede FC, da Cruz L, Stephens C et al (2003) Long-term evaluation of retinal function in Prph2Rd2/Rd2 mice following AAV-mediated gene replacement therapy. J Gene Med 5:757-764 (Pubitemid 40309713)
12. Alexander JJ, Umino Y, Everhart D et al (2007) Restoration of cone vision in a mouse model of achromatopsia. Nat Med 13:685-687 (Pubitemid 46889758)
13. Janssen A, Min SH, Molday LL et al (2008) Effect of late-stage therapy on disease progression in AAV-mediated rescue of photoreceptor cells in the retinoschisin-de fi cient mouse. Mol Ther 16:1010-1017 (Pubitemid 351737064)
14. Cideciyan AV, Hauswirth WW, Aleman TS et al (2009) Human RPE65 gene therapy for Leber congenital amaurosis: Persistence of early visual improvements and safety at 1 year. Hum Gene Ther 20:999-1004
15. Simonelli F, Maguire AM, Testa F et al (2010) Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration. Mol Ther 18:643-650
16. Pal fi A, Millington-Ward S, Chadderton N et al (2010) Adeno-associated virus-mediated rhodopsin replacement provides therapeutic bene fi t in mice with a targeted disruption of the rhodopsin gene. Hum Gene Ther 21:311-323
17. Sun X, Pawlyk B, Xu X et al (2010) Gene therapy with a promoter targeting both rods and cones rescues retinal degeneration caused by AIPL1 mutations. Gene Ther 17:117-131
18. Towne C, Setola V, Schneider BL et al (2011) Neuroprotection by gene therapy targeting mutant SOD1 in individual pools of motor neurons does not translate into therapeutic bene fi t in fALS mice. Mol Ther 19:274-283
19. Lhériteau E, Libeau L, Mendes-Madeira A et al (2010) Regulation of retinal function but nonrescue of vision in RPE65-de fi cient dogs treated with doxycycline-regulatable AAV vectors. Mol Ther 18:1085-1093
20. Bainbridge JW, Mistry A, Schlichtenbrede FC et al (2003) Stable rAAV-mediated transduction of rod and cone photoreceptors in the canine retina. Gene Ther 10:1336-1344 (Pubitemid 36987124)
21. Liang FQ, Anand V, Maguire AM et al (2001) Intraocular delivery of recombinant virus. Methods Mol Med 47:125-139
22. Michalakis S, Mühlfriedel R, Tanimoto N et al (2010) Restoration of cone vision in the CNGA3 / mouse model for congenital complete lack of cone photoreceptor function. Mol Ther 18:2057-2063